Novamind (OTC: NVMDF) Partners with Merck (NYSE: MRK) for New Treatment-Resistant Depression Trial
Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site TORONTO, ON / March 18, 2021 / Novamind Inc., (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic […]
